133 related articles for article (PubMed ID: 8256726)
1. Usefulness and tolerability of hirulog, a direct thrombin-inhibitor, in unstable angina pectoris.
Sharma GV; Lapsley D; Vita JA; Sharma S; Coccio E; Adelman B; Loscalzo J
Am J Cardiol; 1993 Dec; 72(18):1357-60. PubMed ID: 8256726
[TBL] [Abstract][Full Text] [Related]
2. Hirulog in the treatment of unstable angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial.
Fuchs J; Cannon CP
Circulation; 1995 Aug; 92(4):727-33. PubMed ID: 7641350
[TBL] [Abstract][Full Text] [Related]
3. Initial experience with a direct antithrombin, Hirulog, in unstable angina. Anticoagulant, antithrombotic, and clinical effects.
Lidón RM; Théroux P; Juneau M; Adelman B; Maraganore J
Circulation; 1993 Oct; 88(4 Pt 1):1495-501. PubMed ID: 8403297
[TBL] [Abstract][Full Text] [Related]
4. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators.
Bittl JA; Strony J; Brinker JA; Ahmed WH; Meckel CR; Chaitman BR; Maraganore J; Deutsch E; Adelman B
N Engl J Med; 1995 Sep; 333(12):764-9. PubMed ID: 7643883
[TBL] [Abstract][Full Text] [Related]
5. Comparative safety profiles of hirulog and heparin in patients undergoing coronary angioplasty. The Hirulog Angioplasty Study Investigators.
Bittl JA
Am Heart J; 1995 Sep; 130(3 Pt 2):658-65. PubMed ID: 7668214
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery disease.
Cannon CP; Maraganore JM; Loscalzo J; McAllister A; Eddings K; George D; Selwyn AP; Adelman B; Fox I; Braunwald E
Am J Cardiol; 1993 Apr; 71(10):778-82. PubMed ID: 8456753
[TBL] [Abstract][Full Text] [Related]
7. [Unstable angina pectoris: coagulation disorder and its therapy].
Meyer BJ
Praxis (Bern 1994); 1995 Feb; 84(8):232-8. PubMed ID: 7886362
[TBL] [Abstract][Full Text] [Related]
8. Bivalirudin: a review of its potential place in the management of acute coronary syndromes.
Carswell CI; Plosker GL
Drugs; 2002; 62(5):841-70. PubMed ID: 11929334
[TBL] [Abstract][Full Text] [Related]
9. Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty.
Topol EJ; Bonan R; Jewitt D; Sigwart U; Kakkar VV; Rothman M; de Bono D; Ferguson J; Willerson JT; Strony J
Circulation; 1993 May; 87(5):1622-9. PubMed ID: 8491018
[TBL] [Abstract][Full Text] [Related]
10. Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction.
Théroux P; Pérez-Villa F; Waters D; Lespérance J; Shabani F; Bonan R
Circulation; 1995 Apr; 91(8):2132-9. PubMed ID: 7697841
[TBL] [Abstract][Full Text] [Related]
11. Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial.
Topol EJ; Fuster V; Harrington RA; Califf RM; Kleiman NS; Kereiakes DJ; Cohen M; Chapekis A; Gold HK; Tannenbaum MA
Circulation; 1994 Apr; 89(4):1557-66. PubMed ID: 8149521
[TBL] [Abstract][Full Text] [Related]
12. A pilot, early angiographic patency study using a direct thrombin inhibitor as adjunctive therapy to streptokinase in acute myocardial infarction.
Lidón RM; Théroux P; Lespérance J; Adelman B; Bonan R; Duval D; Lévesque J
Circulation; 1994 Apr; 89(4):1567-72. PubMed ID: 8149522
[TBL] [Abstract][Full Text] [Related]
13. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.
Lancet; 1999 Feb; 353(9151):429-38. PubMed ID: 9989712
[TBL] [Abstract][Full Text] [Related]
14. Hirudin and hirudin analogues as new anticoagulant agents.
Pineo GF; Hull RD
Curr Opin Hematol; 1995 Sep; 2(5):380-5. PubMed ID: 9372023
[TBL] [Abstract][Full Text] [Related]
15. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
[TBL] [Abstract][Full Text] [Related]
16. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
Rao AK; Sun L; Chesebro JH; Fuster V; Harrington RA; Schwartz D; Gallo P; Matos D; Topol EJ
Circulation; 1996 Nov; 94(10):2389-95. PubMed ID: 8921778
[TBL] [Abstract][Full Text] [Related]
17. Hirudin: clinical potential of a thrombin inhibitor.
Johnson PH
Annu Rev Med; 1994; 45():165-77. PubMed ID: 8198374
[TBL] [Abstract][Full Text] [Related]
18. [Direct thrombin antagonists].
Lankes W; Fleischer K; Gulba DC
Herz; 2001 Apr; 26 Suppl 1():46-52. PubMed ID: 11349627
[TBL] [Abstract][Full Text] [Related]
19. Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data.
Direct Thrombin Inhibitor Trialists' Collaborative Group
Lancet; 2002 Jan; 359(9303):294-302. PubMed ID: 11830196
[TBL] [Abstract][Full Text] [Related]
20. Hirulog: a direct thrombin inhibitor for management of acute coronary syndromes.
Maraganore JM; Adelman BA
Coron Artery Dis; 1996 Jun; 7(6):438-48. PubMed ID: 8889359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
